Cogent Biosciences, Inc. (COGT)

Cogent Biosciences Statistics

Total Valuation

COGT has a market cap or net worth of $5.13 billion. The enterprise value is $4.80 billion.

Market Cap	5.13B
Enterprise Value	4.80B

Important Dates

The last earnings date was Monday, November 3, 2025, before market open.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

COGT has 152.13 million shares outstanding. The number of shares has increased by 21.79% in one year.

Current Share Class	152.05M
Shares Outstanding	152.13M
Shares Change (YoY)	+21.79%
Shares Change (QoQ)	+20.15%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	86.07%
Float	116.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	24.27
P/TBV Ratio	26.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.38, with a Debt / Equity ratio of 0.20.

Current Ratio	6.38
Quick Ratio	6.28
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-173.49

Financial Efficiency

Return on equity (ROE) is -95.40% and return on invested capital (ROIC) is -55.28%.

Return on Equity (ROE)	-95.40%
Return on Assets (ROA)	-47.47%
Return on Invested Capital (ROIC)	-55.28%
Return on Capital Employed (ROCE)	-84.58%
Revenue Per Employee	n/a
Profits Per Employee	-$1.44M
Employee Count	205
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +279.21% in the last 52 weeks. The beta is 0.64, so COGT's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+279.21%
50-Day Moving Average	16.92
200-Day Moving Average	10.22
Relative Strength Index (RSI)	82.68
Average Volume (20 Days)	4,752,892

Short Selling Information

The latest short interest is 15.05 million, so 9.90% of the outstanding shares have been sold short.

Short Interest	15.05M
Short Previous Month	16.28M
Short % of Shares Out	9.90%
Short % of Float	12.92%
Short Ratio (days to cover)	6.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-307.60M
Pretax Income	-294.37M
Net Income	-294.37M
EBITDA	-305.04M
EBIT	-307.60M
Earnings Per Share (EPS)	-$2.47

Balance Sheet

The company has $390.89 million in cash and $60.56 million in debt, giving a net cash position of $330.33 million or $2.17 per share.

Cash & Cash Equivalents	390.89M
Total Debt	60.56M
Net Cash	330.33M
Net Cash Per Share	$2.17
Equity (Book Value)	302.46M
Book Value Per Share	1.39
Working Capital	335.00M

Cash Flow

In the last 12 months, operating cash flow was -$245.92 million and capital expenditures -$818,000, giving a free cash flow of -$246.73 million.

Operating Cash Flow	-245.92M
Capital Expenditures	-818,000
Free Cash Flow	-246.73M
FCF Per Share	-$1.62

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

COGT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.79%
Shareholder Yield	-21.79%
Earnings Yield	-5.73%
FCF Yield	-4.81%

Analyst Forecast

The average price target for COGT is $28.08, which is -16.80% lower than the current price. The consensus rating is "Buy".

Price Target	$28.08
Price Target Difference	-16.80%
Analyst Consensus	Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 9, 2020. It was a reverse split with a ratio of 1:4.

Last Split Date	Nov 9, 2020
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1